[Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
Specchia
G
G
Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi, Policlinico San Matteo, IRCCS, Pavia.
Marsico
F
F
Micheletti
T
T
Bona
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005080:Exercise Test; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000188:drug therapy; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D020108:Nicorandil; D015221:Potassium Channels / Q000819:agonists* / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D015221:Potassium Channels; D014665:Vasodilator Agents; D009536:Niacinamide; D020108:Nicorandil; D007548:Isosorbide Dinitrate